Healthcare and Pharmaceuticals
The global proton therapy market size was valued at USD 1314.6 million in 2023, driven by increased cancer prevalence across the globe. The market size is anticipated to grow at…
The Primary Myelofibrosis market size was valued at USD 877.43 million in 2023, driven by increasing development of novel therapies. The market size is anticipated to grow at a CAGR…
The polycythemia vera market size is anticipated to grow at a CAGR of 14% during the forecast period of 2024-2032, driven by development of new diagnostic biomarkers. Polycythemia Vera: Introduction…
The Vietnam interventional cardiology market size was valued at USD 0.8 billion in 2023, driven by a growing preference for minimally invasive procedures among both healthcare professionals and patients. The…
The Type 1 diabetes market size was valued at USD 7.9 billion in 2023, driven increasing prevalence of Type 1 diabetes across the major markets. The market size is anticipated…
The treatment resistant depression market was valued at USD 3295 million in 2023, driven growing emphasis on personalized or precision medicine across the major markets. The market size is anticipated…
The Tay Sachs disease market size was valued at USD 2.3 billion in 2023, driven by the increasing investment in the domain across the major markets. The market size is…
The tardive dyskinesia market size is anticipated to grow at a CAGR of 3.2 % during the forecast period of 2024-2032, driven by growing awareness about the importance of monitoring…
The Sezary syndrome market size was valued at USD 745.2 million in 2023, driven by the increasing research activity in new drug development across the 7 major markets. The market…
The Sandhoff disease market size was valued at USD 10.18 billion in 2023, driven growing interest in gene therapy as a potential curative approach across the major markets. The market…